Osimertinib With Chemotherapy Improves OS in Patients With EGFRm NSCLC
The combination regimen had stronger benefits in patients with locally advanced or metastatic epidermal growth receptor-mutated (EGFRm) non–small cell lung…
https://prabadinews.com/